www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

China sets more funds for HIV research

Updated: 2011-09-15 07:28

By Shan Juan (China Daily)

  Comments() Print Mail Large Medium  Small 分享按鈕 0

BANGKOK - China invested more than $18 million in HIV vaccine research and development in 2010, becoming the third largest contributor globally, after the United States and the European Union, according to a report endorsed by UNAIDS.

Internationally, HIV vaccine research and development (R&D) funding stood at $859 million last year, $9 million less than 2009, while China increased its spending by nearly $4 million over the same period, said the global report issued jointly by international organizations including AIDS Vaccine Advocacy Coalition (AVAC) and Intentional AIDS Vaccine Initiative.

"The long-term nature of vaccine research will require sustained investments globally and more developing countries like China are expected to shoulder more responsibilities," Kevin Fisher, the coalition's policy director said at the 2011 AIDS Vaccine Conference, which opened on Tuesday.

Unfortunately, overall global funding for HIV R&D has flattened out since 2000 and some early supporters, such as Canada and Sweden, have cut back, said the report. In the EU, a major contributor, funding has declined by 23 per cent since 2007.

In contrast, the Chinese government has pledged to further boost funding for HIV vaccine development by at least 20 percent in five years, according to Shao Yiming, director of the virology and immunology department of the National Center for AIDS/STD Control and Prevention.

Currently, China has four major HIV vaccine candidates under development on the mainland, all financed by the government.

"Compared with many developed countries like the US, which has dozens of HIV vaccine candidates under development, China needs more to have a better chance of success," Shao said.

His team is now waiting for approval from China's drug authorities to enter the second phase of the clinical trial for their HIV vaccine candidate, Tiantan.

Usually a vaccine has to undergo three phases of human trials before being licensed for use, experts said. The first two phases mainly test its safety and the third mainly its efficacy.

By May, 24 HIV vaccine candidates had entered the human trial stages across the world, including Tiantan, which is the only one from China to have reached that point.

Shao urged the Chinese government to regularly increase funding for vaccine development, particularly when some attention has been diverted to new prevention measures with proven efficacy.

"An effective and affordable vaccine is unanimously recognized as the ultimate weapon against HIV/AIDS worldwide," he said.

"The funding and human resources for vaccine R&D in China should be diversified and stakeholders like charities and industry should join in the effort."

Currently, all such studies on the mainland are funded and organized by the government, he said.

Half of the resources come from non-public sectors like pharmaceutical companies and philanthropic organizations, according to Shao.

As well, Kevin Fisher called on the Chinese government to be more transparent and to collaborate with international researchers in HIV vaccine development.

He said the Chinese authorities were usually reluctant to share relevant information, such as the amount of investment, with international stakeholders.

主站蜘蛛池模板: 成人爽a毛片在线视频 | 精品成人一区二区三区免费视频 | 日韩一区二区三区免费视频 | 亚洲视频网址 | 亚洲视频在线播放 | 在线一级片 | 国产欧美日韩不卡一区二区三区 | 日本精品久久久久中文字幕 1 | 手机看片精品国产福利盒子 | 特级一级毛片视频免费观看 | 香蕉久久夜色精品国产 | 亚洲免费在线播放 | 欧美成人在线免费观看 | 久久国产精品1区2区3区网页 | 成人精品在线视频 | 久久精品视频网 | 国产高清视频免费最新在线 | 99福利资源久久福利资源 | 成人久久久观看免费毛片 | 色综合久久综合 | 国产成人ay手机在线观看 | 久久亚洲国产午夜精品理论片 | 九九九九在线视频播放 | 国产啪精品视频网免费 | 911精品国产91久久久久 | 日韩在线观看中文字幕 | jul-179在线中文字幕 | 欧美午夜精品久久久久免费视 | 亚洲国产日韩欧美高清片a 亚洲国产日韩欧美在线 | 亚洲国产精品日韩高清秒播 | 一区二区三区不卡在线 | 精品国产欧美另类一区 | 爽爽窝窝午夜精品一区二区 | 99久久精品男女性高爱 | 欧美一级片在线免费观看 | 三级全黄的全黄三级三级播放 | 成人免费看毛片 | 99视频免费观看 | 欧美一区二区三区免费不卡 | 欧美中文字幕在线视频 | 欧美成人精品久久精品 |